Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,082 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.
Terzi M, Helvacı EM, Şen S, Boz C, Çilingir V, Akçalı A, Beckmann Y, Uzunköprü C, Türkoğlu R, Yüceyar N, Efendi H, Bünül SD, Seferoğlu M, Kotan D, Güler S, Balcı BP, Öztürk B, Mungan S, İçen NK, Ömerhoca S, Yurtoğulları Ş, Sevim S, Türkoğlu ŞA, Çam M, Yetkin MF, Yoldaş TK, Sıvacı AÖ, Gökçe ŞF, Gürsoy E, Ünal A, Bilge N, Ağan K, Toprak MK, Koçer B, Sezer G, Terzi Y. Terzi M, et al. Among authors: sen s. Noro Psikiyatr Ars. 2023 Jan 13;60(1):23-27. doi: 10.29399/npa.28081. eCollection 2023. Noro Psikiyatr Ars. 2023. PMID: 36911568 Free PMC article.
Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial.
Ozakbas S, Turkoglu R, Tamam Y, Terzi M, Taskapilioglu O, Yucesan C, Baser HL, Gencer M, Akil E, Sen S, Turan OF, Sorgun MH, Yigit P, Turkes N. Ozakbas S, et al. Among authors: sen s. Mult Scler Relat Disord. 2018 May;22:70-76. doi: 10.1016/j.msard.2018.03.009. Epub 2018 Mar 24. Mult Scler Relat Disord. 2018. PMID: 29605801
Neurostatus and EDSS Calculation with Cases.
Şen S. Şen S. Noro Psikiyatr Ars. 2018;55(Suppl 1):S80-S83. doi: 10.29399/npa.23412. Noro Psikiyatr Ars. 2018. PMID: 30692863 Free PMC article. Review.
'Is RLS a harbinger and consequence of MS?: Striking results of the 'RELOMS-T' study'.
Sevim S, Demirkıran M, Terzi M, Yüceyar N, Taşdelen B, İdiman E, Kürtüncü M, Boz C, Tuncel D, Karabudak R, Siva A, Özcan A, Neyal M, Göksel BK, Balal M, Şen S, Ekmekçi Ö, Öksüz N, Kaya D. Sevim S, et al. Among authors: sen s. Mult Scler Relat Disord. 2020 Jul;42:102055. doi: 10.1016/j.msard.2020.102055. Epub 2020 Mar 16. Mult Scler Relat Disord. 2020. PMID: 32473575
The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey.
Uzunköprü C, Tütüncü M, Gündüz T, Gümüş H, Şen S, Demir S, Çınar BP, Türe HS, Uygunoğlu U, Toğrol RE, Terzi M, Kürtüncü M, Özakbaş S, Tütüncü M, Beckmann Y, Siva A. Uzunköprü C, et al. Among authors: sen s. Int J Clin Pract. 2021 Jul;75(7):e14158. doi: 10.1111/ijcp.14158. Epub 2021 Apr 8. Int J Clin Pract. 2021. PMID: 33743552
The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?
Sen S, Karabudak R, Schiavetti I, Demir S, Ozakbas S, Tutuncu M, Petek Balci B, Turan OF, Uzunkopru C, Koseoglu M, Yetkin MF, Gunduz T, Gumus H, Kale Icen N, Carmisciano L, Terzi M, Acar P, Gungor Dogan I, Baba C, Tuncer A, Uygunoglu U, Sormani MP, Efendi H, Siva A; Turkish MS Study Group. Sen S, et al. Mult Scler Relat Disord. 2021 Jul;52:102968. doi: 10.1016/j.msard.2021.102968. Epub 2021 Apr 18. Mult Scler Relat Disord. 2021. PMID: 33940495 Free PMC article.
5,082 results